Oxidative stress caused by glycation of Cu,Zn-superoxide dismutase and its effects on intracellular components

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 5, 1996, Pages 34-40

  Fujii, Junichi ^a   Myint, Theingi ^a   Okado, Ayako ^a   Kaneto, Hideaki ^a   Taniguchi, Naoyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Aldo keto reductase; Amyotrophic lateral sclerosis; Reactive oxygen intermediates; Superoxide dismutase

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; REACTIVE OXYGEN METABOLITE;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; CELL DEATH; CONFERENCE PAPER; ENZYME GLYCOSYLATION; FAMILIAL DISEASE; GLYCATION; HUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030483886     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp5.34     Document Type: Conference Paper

References (36)

1. Monnier VM. Toward a Maillard reaction theory of aging. In: Baynes JW, Monnier VM, eds. The Maillard Reaction in Aging, Diabetes and Nutrition. Alan R. Liss, New York, 1989; 1-22
2. Arai K, Iizuka S, Tada Y, Oikawa K, Taniguchi N. Increase in the glucosylated form of erythrocyte Cu,Zn-superoxide dismutase in diabetes and close association of the nonenzymatic glucosylation with the enzyme activity. Biochim Biophys Acta 1987; 924: 292-296
3. Arai K, Maguchi S, Fujii S, Ishibashi H, Oikawa K, Taniguchi N. Glycation and inactivation of human Cu-Zn-superoxide dismutase. Identification of the in vitro glycation sites. J Biol Chem 1987; 262: 16969-16972
4. Kondo T, Murakami K, Ohtuka Y, Tsuji M, Gasa S, Taniguchi N, Kawakami Y. Estimation and characterization of glycosylated carbonic anhydrase I in erythrocytes from patients with diabetes mellitus. Clin Clin Acta 1987; 166: 227-236
5. Shilton BH, Walton DJ. Sites of glycation of human and horse liver alcohol dehydrogenase in vivo. J Biol Chem 1991; 266: 5587-5592
6. Takahashi M, Lu Y, Myint T, Fujii J, Wada Y, Taniguchi N. In vivo glycation of aldehyde reductase, a major 3-deoxyglucosone reducing enzyme. Identification of glycation sites. Biochemistry 1995; 34: 1433-1438
7. Garner MH, Bahador A, Sachs G. Nonenzymatic glycation of Na,K-ATPase: effect of ATP hydrolysis and K+ occlusion. J Biol Chem 1990; 265: 15058-15066
8. Sakurai T, Tsuchiya S. Superoxide production from nonenzymatically glycated protein. FEBS Lett 1988; 236: 406-410
9. Mullarkey CJ, Edelstein D, Bronlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 1990; 173: 932-939
10. Takahashi M, Fujii J, Teshima T, Suzuki K, Shiba T, Taniguchi N. Identity of a major 3-deoxyglucosone-reducing enzyme with aldehyde reductase in rat liver established by amino acid sequencing and cDNA expression. Gene 1995; 127: 249-253
11. Tomlinson DR, Stevens EJ, Diemel CT. Aldose reductase inhibitors and their potential for the treatment of diabetic complications. Trends Pharmacol Sci 1994; 15: 293-297
12. Takahashi M, Fujii J, Miyoshi E, Hoshi A, Taniguchi N. Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int J Cancer 1995; 62: 749-754
13. Takahashi M, Hoshi A, Fujii J et al. Induction of aldose reductase gene expression in LEC rats during the development of hereditary hepatitis and hepatoma. Jpn J Cancer Res in press
14. Taniguchi N. Clinical significances of superoxide dismutases: changes in aging, diabetes, ischemia, and cancer. Adv Clin Chem 1992; 29: 1-59
15. Kawamura N, Ookawara T, Suzuki K, Konishi K, Mino M, Taniguchi N. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992; 74: 1352-1354
16. Ookawara T, Kawamura N, Kitagawa Y, Taniguchi N. Sitespecific and random fragmentation of Cu,Zn-superoxide dismutase by glycation reaction. Implication of reactive oxygen species. J Biol Chem 1992; 267: 18505-18510
17. Islam KN, Takahashi M, Higashyama S et al. Fragmentation of ceruloplasmin following non-enzymatic glycation reaction. J Biochem 1995; 118: 1054-1060
18. Kaneto H, Fujii J, Suzuki K et al. DNA cleavage induced by glycation of Cu,Zn-superoxide dismutase. Biochem J 1994; 304: 219-225
19. Rosen, DR, Siddique T, Patterson D et al. Mutations in Cu/Zn-superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62
20. Nakano R, Sato S, Inuzuka T et al. A novel mutation in Cu/Zn superoxide dismutase gene in a Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 200: 695-703
21. Hirano M, Fujii J, Nagai Y et al. A new variant Cu/Zn superoxide dismutase (Val7 → Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994; 204: 572-577
22. Brown RH, Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692
23. Deng H-X, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993; 261: 1047-1051
24. Borchelt DR, Lee MK, Slunt HS et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994; 91: 8292-8296
25. Rabizadeh S, Gralla EB, Borchelt DR et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to proapoptotic gene: studies in yeast and neuronal cells. Proc Natl Acad Sci USA 1995; 92: 3024-3028
26. Rothstein JD, Bristol LA, Hosler B, Brown RH, Jr, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci USA 1994; 91: 4155-4159
27. Troy CM, Shelanski ML. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci USA 1994; 91: 6384-6387
28. Gurnery ME, Pu H, Chiu AY et al. Motor neuron degradation in mice that express a human Cu,Zn-superoxide dismutase mutation. Science 1994; 264: 1772-1775
29. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Nail Acad Sci USA 1995; 92: 689-693
30. Yim MB, Chock PB, Stadtman ER. Copper,zinc superoxide dismutase catalyzes hydroxyl radical production from hydrogen peroxide. Proc Natl Acad Sci USA 1990; 87: 5006-5010
31. Yim MB, Chock PB, Stadtman ER. Enzyme function of copper,zinc superoxide dismutase as a free radical generator. J Biol Chem 1993; 268: 4099-4105
32. 2 plus Cu,Zn-superoxide dismutase reflects the activity of free copper released from the oxidatively damaged enzyme. J Biol Chem 1992; 267: 25371-25377
33. Fujii J, Myint T, Seo HG, Kayanoki Y, Ikeda Y, Taniguchi N. Characterization of wild-type and amyotrophic lateral sclerosis-related mutant Cu,Zn-superoxide dismutases overproduced in baculovirus-infected insect cells. J Neurochem 1995; 64: 1456-1461
34. Omar BA, Gad NM, Jordan MC et al. Cardioprotection by Cu,Zn-superoxide dismutase is lost at high doses in the oxygenated heart. Free Rod Biol Med 1990; 4: 9-14
35. Poulton KR, Rossi ML. Peripheral nerve protein glycation and muscle fructolysis: evidence of abnormal carbohydrate metabolism in ALS. Funct Neurol 1993; 8: 33-42
36. Myint T, Hoshi S, Ookawara T, Miyazawa N, Suzuki K, Taniguchi N. Immunological detection of glycated proteins in normal and streptozotocin-induced diabetic rats using anti hexitol-lysine IgG. Biochim Biophys Acta 1995; 1272: 73-79